INVENTIA
Para deferir Designação Recebida (sem interposição de recurso contra o deferimento parcial)
Marca Nominativa depositada no INPI em
14/07/2023 por Inventia Pty Ltd,
processo nº 501767671, nas classes 01, 05, 07, 09, 10, 35, 42.
O processo ainda está em andamento no INPI.
| Número do processo | 501767671 |
|---|
| Situação | Para deferir Designação Recebida (sem interposição de recurso contra o deferimento parcial) |
|---|
| Apresentação | Nominativa |
|---|
| Natureza | Madri
Produto/Serviço |
|---|
| Data do depósito | 14/07/2023 |
|---|
| Data da concessão | — |
|---|
| Vigência até | 14/07/2033 |
|---|
| Titular | Inventia Pty Ltd |
|---|
| CNPJ/CPF do titular | — |
|---|
| UF · País | — · AU |
|---|
Classes e especificação
Biological materials and products, preparations and substances(other than for medical use); reagents and consumablesfor biological materials and products, cell maintenance andgrowth; biological samples and cells, including living, functionalcellular structures for use in scientific and medical research;fine chemicals; chemical and biological reagents; chemicalpreparations for scientific purposes; none of the foregoingbeing in relation to oral or injectable therapies for the treatmentof patient needs in the areas of fibrosis, lysosomal storagedisorders and oncology, cardiometabolic diseases, liverdiseases, metabolic disorders (including obesity, diabetes,severe dyslipidemias, NASH), inflammatory diseases andautoimmune diseases.;
Surgical grafts (living tissues); engineered living tissues and 3Dcell cultures for medical and surgical use; tissue-regenerativemedical preparations; biological tissue cultures for medicalpurposes; biological preparations use for in cell cultures(medical); engineered biological tissues and cells for medicaluses; reagents in this class, not being biological reagents formedical purposes; cell culture media.;
3D printers; computerised equipment for the generation of3D shaped parts; machines, namely, 3D bioprinters for theprinting of living cells and tissues or printing 3D cell structures;cartridges for containing printing materials; cartridges forcontaining bioprinting materials; printing cartridges forcontaining biomaterials and reagents; printing cartridges forcontaining bio-ink; robotic handling apparatus; accessoriesand spare parts for three dimensional (3D) printers for theproduction of biological materials, namely print heads forthree dimensional (3D) printers; machines, namely, threedimensional (3D) printer for the printing of engineered livingtissues; three dimensional (3D) printers; parts and fittingstherefor; none of the foregoing being in relation to oral orinjectable therapies for the treatment of patient needs in theareas of fibrosis, lysosomal storage disorders and oncology,cardiometabolic diseases, liver diseases, metabolic disorders(including obesity, diabetes, severe dyslipidemias, NASH),inflammatory diseases and autoimmune diseases.;
Laboratory robots; downloadable software, including softwarefor monitoring and controlling communication betweencomputers and automated machine systems, software foroperating and controlling 3D printers, downloadable operatingsoftware to control laboratory apparatus for fabrication of threedimensional (3D) engineered living tissues, and software forthe purpose of the manufacture of products by means of a 3Dprinter, including medical products; electronic components for use in connection with laboratory robots; laboratory instrumentsand apparatus, including cell assembly apparatus for laboratoryuse for fabrication of three dimensional (3D) engineered livingtissues; print heads; electronic publications; parts and fittingsfor all of the foregoing, including electronic control panelswith digital displays for the control of three dimensional (3D)printers; none of the foregoing being in relation to oral orinjectable therapies for the treatment of patient needs in theareas of fibrosis, lysosomal storage disorders and oncology,cardiometabolic diseases, liver diseases, metabolic disorders(including obesity, diabetes, severe dyslipidemias, NASH),inflammatory diseases and autoimmune diseases.;
Robotic apparatus for medical or surgical purposes; robotsfor medical or surgical purposes; apparatus and instrumentsfor medical use; medical apparatus for use in the treatmentof injuries; parts and fittings therefor; none of the foregoingbeing in relation to oral or injectable therapies for the treatmentof patient needs in the areas of fibrosis, lysosomal storagedisorders and oncology, cardiometabolic diseases, liverdiseases, metabolic disorders (including obesity, diabetes,severe dyslipidemias, NASH), inflammatory diseases andautoimmune diseases.;
Data management; retail and wholesale services forpharmaceutical, medical, scientific, laboratory and 3D printingconsumables and supplies; administrative processing ofpurchase orders; computerised stock ordering and purchasing;computerised data processing; compilation of scientificinformation; maintenance of registers (for others), includingregisters relating to device history and maintenance history;none of the foregoing being in relation to oral or injectabletherapies for the treatment of patient needs in the areasof fibrosis, lysosomal storage disorders and oncology,cardiometabolic diseases, liver diseases, metabolic disorders(including obesity, diabetes, severe dyslipidemias, NASH),inflammatory diseases and autoimmune diseases.;
Scientific and technological services and research anddesign relating thereto; industrial analysis, industrial researchand industrial design services; design and development ofcomputer software; software-as-a-service; provision of onlinenon-downloadable software (application service provider);computer support services (programming and softwareinstallation, repair and maintenance services); analysisof statistical data for scientific research; design services,including design of software, design of biological materials,design services relating to printing and product design;research relating to design; laboratory research; biomedicalresearch; cloud computing; advisory services relating toscientific products and scientific research; scientific researchinto the development of new products; providing technicalsupport services regarding medical and diagnostic laboratoryinstruments and systems; web-based software platform forlaboratory and diagnostic equipment information management,monitoring and analysis; providing information, includingonline, about all of the foregoing; none of the foregoing beingin relation to oral or injectable therapies for the treatmentof patient needs in the areas of fibrosis, lysosomal storagedisorders and oncology, cardiometabolic diseases, liverdiseases, metabolic disorders (including obesity, diabetes,severe dyslipidemias, NASH), inflammatory diseases andautoimmune diseases.;